Waltham, MA, November 5, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, announced the winners of the TGaS Best of Benchmark (BoB) Awards. The Awards, which are given for commercial operations excellence within the pharmaceutical industry, were presented to teams at Merck (known as MSD outside the United States and Canada), Gilead, Sanofi, Janssen Oncology, Genentech and Horizon Therapeutics. The BoBs are based on TGaS benchmarking of large, midsize and emerging life sciences companies.
While the…
Read Now
WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life sciences solutions, introduces a new field force impact benchmarking service called Trinity Stakeholder Voice. The service offers critical insights for biopharmaceutical companies looking to lead the market in a new and changing reality.
Stakeholder Voice reveals how healthcare providers really feel about their pharmaceutical sales representatives and/or medical science liaisons. The service allows biopharma companies to benchmark how their frontline teams are doing in terms of outreach frequency and quality…
Read Now
WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life science solutions, has published a comprehensive report entitled Launching During COVID-19, Assessing the Damage and Finding Success. The paper uncovers some surprising and concerning issues related to launching a drug during COVID-19, details case studies of drugs that have launched during the pandemic and provides important takeaways for life science companies now preparing for launch.
According to the white paper, it is possible to successfully launch a new product during…
Read Now
Waltham, MA, October 21, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, is sharing findings from its latest TGaS Landscape report entitled, “Tenth Annual Incentive Compensation Landscape.” This detailed report is based on interviews of 38 biopharmaceutical incentive compensation (IC) leaders who shared their experience on IC planning including:
Challenges and the FuturePlan MechanicsGoal SettingContests and SPIFFs (sales performance incentive funds)President’s ClubAdjustmentsIC Governance
The benefit of publishing the report every year allows its authors to reveal…
Read Now
Waltham, MA, September 21, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, introduces Trinity EvidenceFirst™, a high-value subscription service that allows biopharmaceutical companies to take advantage of real-world insights like never before. EvidenceFirst allows organizations to benefit from big, robust data without dealing with the complexities, resource requirements, and costs associated with large data sets. With EvidenceFirst, biopharmaceutical companies can now utilize real-world insights on a broader range of projects with faster turnaround times.
The combination…
Read Now
Waltham, MA, September 16, 2020 – Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Rebecca McNamara as Chief Financial Officer (CFO) reporting directly to Dave Fitzhenry, Trinity’s CEO.
Ms. McNamara has a proven track record for leading growth strategies as well as complex operational initiatives and capital allocation strategies. She joins Trinity from Boston-based Cengage where she most recently served as the Chief Integration Officer. Ms. McNamara will lead Trinity’s already world-class Operations…
Read Now
Waltham, MA, September 9, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, introduces Trinity CloudCast™, the revolutionary connected forecast modeling and management tool that fully leverages Microsoft® Excel®. CloudCast enables biopharma leaders to rapidly create, update, share, and compare scenarios of their demand forecasts with an easy-to-use web app and cloud-based security.
By leveraging Microsoft® Excel® or other commonly-used forecasting software, pharma forecasters can work with tools they know and trust, while generating an unlimited…
Read Now
Waltham, MA, July 27, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, published a new forecasting paper entitled Considerations for Forecasting the Spread of COVID-19: How can life sciences companies most accurately project the spread of COVID-19 to plan for the future? The paper details the steps that life sciences forecasters should take to ensure they are incorporating the right assumptions and data to most accurately project the spread of COVID-19.
The extraordinary worldwide effort to…
Read Now
Waltham, MA, July 22, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, published its newest TGaS report entitled, Commercial/Medical Partnership Landscape: Driving Improvements in Communications, Coordination and Effectiveness. The report finds that pharmaceutical companies that encourage a culture of ‘compliant collaboration’ between Commercial and Medical Affairs teams ensures strong alignment that is critical to a product’s success.
“Often times within pharma, the Commercial and Medical Affairs teams are truly a tale of two cultures – each…
Read Now
Waltham, MA, July 6, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, introduces the first weekly-updated, forecasting model for drugs and treatments impacted by COVID-19. Trinity COVIDCast is a flexible SEIR (susceptible, exposed, infectious, recovered) model that forecasts COVID-19 case counts and hospitalizations across the United States, EU5, China and Japan. COVIDCast is designed for forecasting or brand planning teams working on COVID-specific drugs, diagnostics and vaccines as well as for teams who are working to…
Read Now
